Dissolution of the lymphoid follicle is a feature of the HHV8+variant of plasma cell Castleman's disease

被引:32
作者
Amin, HM [1 ]
Medeiros, LJ [1 ]
Manning, JT [1 ]
Jones, D [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
germinal center; mantle zone; fibroblast; herpesvirus;
D O I
10.1097/00000478-200301000-00010
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The plasma cell variant of Castleman's disease (PCD) may occur in a variety of clinical settings. One recently delineated type of PCD is caused by human herpesvirus 8 (HHV8) infection. Lymph nodes from 25 patients with PCD, including six HHV8+ and 19 HHV8- cases, were studied. Three patients with HHV8+ PCD were also infected with human immunodeficiency virus-1. Features common to all cases were interfollicular plasmacytosis and variably hyperplastic and regressed follicle germinal centers. Features associated only with HHV8+ PCD included follicle dissolution resulting from blurring of the mantle zone boundary (p = 0.0001), presence of atypical plasma cells and immunoblasts within these areas (p = 0.0006), and more prominent interfoilicular vascular proliferation than in HHV8- PCD. HHV8+ cells were predominantly immunoblasts and small lymphocytes that were highly enriched in the mantle zones of altered follicles. These areas showed a predominance of plasmacytoid forms expressing lambda light chain in four of six cases. The extrafollicular fibroblastic network surrounding altered germinal centers demonstrated marked upregulation of low-affinity nerve growth factor receptor in five of five HHV8+ cases but in only two of 10 HHV8-cases. We conclude that HHV8+ PCD is distinctive histologically because of the accumulation of infected lymphocytes in the mantle zone leading to progressive dissolution of the germinal center and altered regulation of the surrounding stroma.
引用
收藏
页码:91 / 100
页数:10
相关论文
共 54 条
  • [1] AbdelReheim FA, 1996, ARCH PATHOL LAB MED, V120, P91
  • [2] Cutaneous and systemic plasmacytosis in a patient of Asian descent living in the United States
    Amin, HM
    McLaughlin, P
    Rutherford, CJ
    Abruzzo, LV
    Jones, D
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2002, 24 (03) : 241 - 245
  • [3] The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element
    An, JB
    Lichtenstein, AK
    Brent, G
    Rettig, MB
    [J]. BLOOD, 2002, 99 (02) : 649 - 654
  • [4] Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6
    Aoki, Y
    Jaffe, ES
    Chang, Y
    Jones, K
    Teruya-Feldstein, J
    Moore, PS
    Tosato, G
    [J]. BLOOD, 1999, 93 (12) : 4034 - 4043
  • [5] G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator
    Bais, C
    Santomasso, B
    Coso, O
    Arvanitakis, L
    Raaka, EG
    Gutkind, JS
    Asch, AS
    Cesarman, E
    Gerhengorn, MC
    Mesri, EA
    [J]. NATURE, 1998, 391 (6662) : 86 - 89
  • [6] ALLEVIATION OF SYSTEMIC MANIFESTATIONS OF CASTLEMANS DISEASE BY MONOCLONAL ANTI-INTERLEUKIN-6 ANTIBODY
    BECK, JT
    HSU, SM
    WIJDENES, J
    BATAILLE, R
    KLEIN, B
    VESOLE, D
    HAYDEN, K
    JAGANNATH, S
    BARLOGIE, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) : 602 - 605
  • [7] Benelli R, 2000, INT J ONCOL, V17, P75
  • [8] INTERLEUKIN-6 PRODUCTION IN B-CELL NEOPLASIAS AND CASTLEMANS DISEASE - EVIDENCE FOR AN ADDITIONAL PARACRINE LOOP
    BURGER, R
    WENDLER, J
    ANTONI, K
    HELM, G
    KALDEN, JR
    GRAMATZKI, M
    [J]. ANNALS OF HEMATOLOGY, 1994, 69 (01) : 25 - 31
  • [9] Heterogeneity of viral IL-6 expression in HHV-8-associated diseases
    Cannon, JS
    Nicholas, J
    Orenstein, JM
    Mann, RB
    Murray, PG
    Browning, PJ
    DiGiuseppe, JA
    Cesarman, E
    Hayward, GS
    Ambinder, RE
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (03) : 824 - 828
  • [10] CASTLEMAN B, 1956, CANCER, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO